Funds for vaccine production in Africa – DW – 06/21/2024

Funds for vaccine production in Africa – DW – 06/21/2024
Funds for vaccine production in Africa – DW – 06/21/2024

The Global Forum for Vaccine Innovation and Sovereignty, co-organized by France, the African Union and the Gavi Vaccine Alliance, an international organization based in Geneva that helps low-income countries introduce vaccines and strengthen their health sovereignty, aims to give a boost to vaccine manufacturers on the continent. Africa only produces 2% of the vaccines used on its soil.

More than a billion dollars were announced Thursday (06.20.2024) at this world vaccination summit to accelerate the production of vaccines in Africa, currently affected by a cholera epidemic. This fund with 1.2 billion dollars (1.1 billion euros) “will be an essential building block for building this true African vaccine market”, according to French President Emmanuel Macron, host of the summit.

Listen to the explanations of Pascal Barollier from GAVI

This browser does not support the audio element.

He also specified that the European Commission will provide “three-quarters of this financing”. Contributions to this new fund – called in English African Vaccine Manufacturing Accelerator (AVMA) – have also been announced by Germany (318 million dollars), France (100 million USD), the United Kingdom (60 million USD). ), alongside other funders (United States, Canada, Norway, Japan and the Bill Gates Foundation).

The Vaccine Alliance (Gavi) used the summit to launch its campaign to replenish its resources.

Pascal Barollier is Gavi’s general director of public engagement and information, and he covers the important points of the forum.

Click on the image to listen to his explanations.

-

-

NEXT Vietnam seeks to increase coffee market share in Canada